NL-OMON53984招募中不适用
Axial Involvement in Psoriatic Arthritis LUMC - AXIS-LUMC
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1) Age >= 18 years.
- •2) Definite diagnosis of PsA.
- •3) Fulfilment of the CASPAR criteria for PsA.
- •4) Duration of PsA symptoms <=10 years.
- •5) Written informed consent.
排除标准
- •1) Unable or unwilling to give informed consent or to comply with the protocol.
- •2) Current or past treatment with biologic or a targeted synthetic
- •disease-modifying antirheumatic drug (DMARDs).
- •3) Contraindications for MRI and/or plain radiograph examination of sacroiliac
- •joints and spine.
研究者
相似试验
Unknown
不适用
Axial Involvement in Psoriatic Arthritis CohortPsoriatic ArthritisNCT04434885Charite University, Berlin, Germany400
进行中（未招募）
不适用
ail involvement in psoriatic arthritis: a cross-sectional and observational prospective study.EUCTR2011-000699-32-BEZ KULeuven, service of Rheumatology
已完成
不适用
ow disease activity in psoriatic arthritis: a cross-sectional analysis of a cohort of patients with Psoriatic Arthritispsoriatic arthritisspondyloarthritis1000381610023213NL-OMON39993Academisch Medisch Centrum250
招募中
不适用
Xiralite in Psoriatic Arthritis for longitudinal measurement of clinical activity using standardized biologic treatmentPsoriasis vulgarisL40.5L40.0Arthropathic psoriasisDRKS00006000Fraunhofer IMEProjektgruppe TMPc/o Universitätsklinikum Frankurt/Main80
进行中（未招募）
不适用
Investigation of the molecular size distribution of hyaluronan and the effect of adalimumab treatment of psoriatic arthritis.EUCTR2012-004940-31-SEDept of medical sciences, Rheumatology